During the past decade, Hôpital Arnaud de Villeneuve conducted 130 clinical trials. In the 10-year time frame, 130 clinical trials started and 33 clinical trials were completed, i.e. on average, 25.4% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 21 clinical trials were completed. i.e. 46.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpital Arnaud de Villeneuve" #1 sponsor was "University Hospital, Montpellier" with 26 trials, followed by "Boehringer Ingelheim" with 12 trials sponsored, "Centre Hospitalier Universitaire de Nīmes" with 12 trials sponsored, "Actelion" with 9 trials sponsored and "Hospices Civils de Lyon" with 9 trials sponsored. Other sponsors include 119 different institutions and companies that sponsored additional 82 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpital Arnaud de Villeneuve" #1 collaborator was "CHU Arnaud de Villeneuve MONTPELLIER" with 2 trials as a collaborator, "Hospices Civils de Lyon" with 2 trials as a collaborator, "Hôpital Necker-Enfants Malades" with 2 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 2 trials as a collaborator and "Ligue contre le cancer, France" with 2 trials as a collaborator. Other collaborators include 71 different institutions and companies that were collaborators in the rest 78 trials.

According to Clinical.Site data, the most researched conditions in "Hôpital Arnaud de Villeneuve" are "Cystic Fibrosis" (16 trials), "Heart Failure" (9 trials), "Asthma" (8 trials), "Leukemia" (5 trials) and "Pulmonary Arterial Hypertension" (5 trials). Many other conditions were trialed in "Hôpital Arnaud de Villeneuve" in a lesser frequency.

Most popular intervention types in "Hôpital Arnaud de Villeneuve" are "Drug" (97 trials), "Other" (33 trials), "Device" (31 trials), "Procedure" (18 trials) and "Biological" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (34 trials), "ELX/TEZ/IVA" (6 trials), "IVA" (6 trials), "Nintedanib" (6 trials) and "etoposide" (6 trials). Other intervention names were less common.

The vast majority of trials in "Hôpital Arnaud de Villeneuve" are 175 trials for "All" genders, 14 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 56 active trials in "Hôpital Arnaud de Villeneuve". 1 are not yet recruiting, 37 are recruiting, 14 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 107 completed trials in Hôpital Arnaud de Villeneuve, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpital Arnaud de Villeneuve, 7 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 13 trials, and there were also 42 trials that are defined as “Not Applicable".